82 related articles for article (PubMed ID: 1791799)
21. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study].
Verder H; Agertoft L; Albertsen P; Christensen NC; Curstedt T; Ebbesen F; Greisen G; Hobolth N; Holm V; Jacobsen T
Ugeskr Laeger; 1992 Jul; 154(31):2136-9. PubMed ID: 1509593
[TBL] [Abstract][Full Text] [Related]
22. Antenatal use of ambroxol for the prevention of infant respiratory distress syndrome.
Laoag-Fernandez JB; Fernandez AM; Maruo T
J Obstet Gynaecol Res; 2000 Aug; 26(4):307-12. PubMed ID: 11049243
[TBL] [Abstract][Full Text] [Related]
23. [Furosemide in newborns infants with idiopathic respiratory insufficiency syndrome].
Vargas Origel A; Jasso Gutiérrez L; Echevarría JL; Reyes Cunningham GE
Bol Med Hosp Infant Mex; 1978; 35(3):517-22. PubMed ID: 580219
[TBL] [Abstract][Full Text] [Related]
24. [Respiratory distress in the newborn (author's transl)].
Nambu H; Anakura M; Tanakawa N; Sawada H
Hokkaido Igaku Zasshi; 1979 May; 54(3):253-63. PubMed ID: 391687
[TBL] [Abstract][Full Text] [Related]
25. Changes in pulmonary function in preterm infants recovering from RDS following early treatment with ambroxol: results of a randomized trial.
Schmalisch G; Wauer RR; Böhme B
Pediatr Pulmonol; 1999 Feb; 27(2):104-12. PubMed ID: 10088933
[TBL] [Abstract][Full Text] [Related]
26. Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome.
Wauer RR; Schmalisch G; Böhme B; Arand J; Lehmann D
Eur J Pediatr; 1992 May; 151(5):357-63. PubMed ID: 1396891
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of ambroxol given prenatally and postnatally on gas exchange in the newborn with respiratory distress syndrome].
Sackey S; Gadzinowski J; Szymankiewicz M; Breborowicz GH; Rudnicki J; Patalan J; Rózewicki K
Ginekol Pol; 1995 Jul; 66(7):409-12. PubMed ID: 8655006
[TBL] [Abstract][Full Text] [Related]
28. Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants.
Jorch G; Hartl H; Roth B; Kribs A; Gortner L; Schaible T; Hennecke KH; Poets C
Pediatr Pulmonol; 1997 Sep; 24(3):222-4. PubMed ID: 9330420
[No Abstract] [Full Text] [Related]
29. Antenatal ambroxol treatment does not prevent the respiratory distress syndrome in premature infants.
Dani C; Grella PV; Lazzarin L; Rubaltelli FF
Eur J Pediatr; 1997 May; 156(5):392-3. PubMed ID: 9177984
[TBL] [Abstract][Full Text] [Related]
30. [The antioxidative and inflammation inhibiting properties of ambroxol].
Winsel K
Pneumologie; 1992 Sep; 46(9):461-75. PubMed ID: 1438126
[No Abstract] [Full Text] [Related]
31. Transcutaneous PO2 and PCO2 during surfactant therapy in newborn infants with idiopathic respiratory distress syndrome.
Oetomo SB; Robertson B; Okken A
Adv Exp Med Biol; 1987; 220():121-2. PubMed ID: 3673752
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effect of micropump intravenous infusion of ambroxol hydrochloride on respiratory distress syndrome in premature infants.
Xu JS; Li BH; Xu YQ; Li J; Lin Y
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5105-5118. PubMed ID: 37318484
[TBL] [Abstract][Full Text] [Related]
33. Postnatal thyroxine administration for idiopathic respiratory distress syndrome in preterm infants.
Amato M; Pasquier S; Carasso A; Von Muralt G
Horm Res; 1988; 29(1):27-30. PubMed ID: 3397040
[TBL] [Abstract][Full Text] [Related]
34. [RDS prevention by prednilyden and ambroxol. A comparative study].
Geibel W; Rindt W; Becker H
Arch Gynecol; 1979 Jul; 228(1-4):204. PubMed ID: 582652
[No Abstract] [Full Text] [Related]
35. A review of surfactant principles in the fetal physiology of man and animals.
Kullander S; Arvidson G; Ekelung L; Astedt B
J Reprod Fertil Suppl; 1975 Oct; (23):659-61. PubMed ID: 1107545
[TBL] [Abstract][Full Text] [Related]
36. [The effectiveness of prenatal steroid and ambroxol therapy for the prevention of respiratory distress syndrome in newborns of diabetic mothers].
Bomba-Opoń DA; Wiczyńska-Zajac A; Domańska-Janczewska E; Kociszewska-Najman B; Marianowski L
Ginekol Pol; 2000 Aug; 71(8):887-92. PubMed ID: 11082943
[TBL] [Abstract][Full Text] [Related]
37. Observation of curative effect of nasal continuous positive airway pressure combined with high-dose ambroxol for neonatal respiratory failure.
Liu Z; Chi J; Feng Z
Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1663-1666. PubMed ID: 30203757
[TBL] [Abstract][Full Text] [Related]
38. Effects and mechanisms of ambroxol inhalation (Mucosolvan
Yang Z; Xiao X; Huang Y; He X; Lu Q; Chen S; Lin Z
Pharmazie; 2017 Oct; 72(10):604-607. PubMed ID: 29441886
[TBL] [Abstract][Full Text] [Related]
39. Alterations of the endoalveolar surfactant after surgery with extracorporeal circulation.
Marcatili S; Guarino C; Giannattasio A; Marcatili A; Festa M; Cautiero V; Marini MG; Pierfederici P; Dell'Orso S; Cotrufo M
Respiration; 1990; 57(4):233-8. PubMed ID: 2095605
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome.
Xiang J; Wang P
Exp Ther Med; 2019 Jul; 18(1):654-658. PubMed ID: 31258703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
